Not every company runs the same fate, everything will come down to the real value of the company, if you really see a future, if you see potential and an uptrend in sales then we will not only stay in Nasdaq but big institutions and large investors will want a piece of the pie and that's when a company worth 50 million goes to be billions of dollars. Let me give you an example, let's say Xyralid becomes the number two seller for hemorrhoid treatment in the world after preparation H and is growing at a faster pace than preparation H, do you think the S/P will go up or down? would you sell your shares? or would you if Fluticare is selling extremely well but the following month will appear on national TV which will boost its sells even more? all I'm saying is this, as long as we have ways to increase revenues year after year the stock is not going to die, whether in Nasdaq or OTC. At this point the future looks fantastic and I don't care if we go to Nasdaq or not, I want us to sell 18 million plus this year and have ways to sell more in 2019.
News 
Market Data 
Discover 
